CAT

773.92

+2.11%↑

GE

314.64

+0.61%↑

RTX

199.99

-0.65%↓

GEV.US

801.92

-1.81%↓

BA

242.96

+1.55%↑

CAT

773.92

+2.11%↑

GE

314.64

+0.61%↑

RTX

199.99

-0.65%↓

GEV.US

801.92

-1.81%↓

BA

242.96

+1.55%↑

CAT

773.92

+2.11%↑

GE

314.64

+0.61%↑

RTX

199.99

-0.65%↓

GEV.US

801.92

-1.81%↓

BA

242.96

+1.55%↑

CAT

773.92

+2.11%↑

GE

314.64

+0.61%↑

RTX

199.99

-0.65%↓

GEV.US

801.92

-1.81%↓

BA

242.96

+1.55%↑

CAT

773.92

+2.11%↑

GE

314.64

+0.61%↑

RTX

199.99

-0.65%↓

GEV.US

801.92

-1.81%↓

BA

242.96

+1.55%↑

Search

Cross Country Healthcare Inc

Закрыт

СекторПромышленность

8.03 1.52

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

7.98

Макс.

8.12

Ключевые показатели

By Trading Economics

Доход

1.9M

-4.8M

Продажи

-24M

250M

Прибыль на акцию

0.03

Рентабельность продаж

-1.909

Сотрудники

9,605

EBITDA

86K

-993K

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+22.9% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

4 мар. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-124M

276M

Предыдущая цена открытия

6.51

Предыдущая цена закрытия

8.03

Новостные настроения

By Acuity

41%

59%

148 / 406 Рейтинг в Industrials

Техническая оценка

By Trading Central

Уверенность

Very Strong Bullish Evidence

Cross Country Healthcare Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

15 февр. 2026 г., 23:21 UTC

Приобретения, слияния, поглощения

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

15 февр. 2026 г., 23:45 UTC

Обсуждения рынка

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

15 февр. 2026 г., 23:40 UTC

Обсуждения рынка

Gold Falls on Possible Position Adjustments -- Market Talk

15 февр. 2026 г., 23:06 UTC

Отчет

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

15 февр. 2026 г., 23:04 UTC

Отчет

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

15 февр. 2026 г., 23:04 UTC

Отчет

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

15 февр. 2026 г., 23:01 UTC

Отчет

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

15 февр. 2026 г., 23:01 UTC

Отчет

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

15 февр. 2026 г., 22:53 UTC

Приобретения, слияния, поглощения

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

15 февр. 2026 г., 22:53 UTC

Приобретения, слияния, поглощения

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

15 февр. 2026 г., 22:52 UTC

Приобретения, слияния, поглощения

Qube Shareholders to Receive A$5.20/Share in Cash

15 февр. 2026 г., 22:52 UTC

Приобретения, слияния, поглощения

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

15 февр. 2026 г., 22:22 UTC

Приобретения, слияния, поглощения

BlueScope CEO Tania Archibald Speaking on a Call With Media

15 февр. 2026 г., 22:17 UTC

Приобретения, слияния, поглощения

BlueScope CEO: Stresses Whyalla Project Would Have to Make Sense to Shareholders

15 февр. 2026 г., 22:16 UTC

Приобретения, слияния, поглощения

BlueScope CEO: Some Job Cuts Inevitable to Ensure Company is Competitive

15 февр. 2026 г., 22:14 UTC

Приобретения, слияния, поглощения

BlueScope CEO: Higher Returns Tied to End of Capital Investment Program

15 февр. 2026 г., 22:14 UTC

Приобретения, слияния, поглощения

BlueScope Steel CEO: Higher Returns After Rebuffed Takeover Bid a 'Natural Coincidence'

15 февр. 2026 г., 20:48 UTC

Отчет

BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed

15 февр. 2026 г., 20:47 UTC

Отчет

BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027

15 февр. 2026 г., 20:46 UTC

Отчет

BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H

15 февр. 2026 г., 20:45 UTC

Отчет

BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H

15 февр. 2026 г., 20:44 UTC

Отчет

BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H

15 февр. 2026 г., 20:44 UTC

Отчет

BlueScope Expects Lower 2H Result From Australia Business Vs 1H

15 февр. 2026 г., 20:43 UTC

Отчет

BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million

15 февр. 2026 г., 20:42 UTC

Отчет

BlueScope Net Debt A$2.2 Million at Dec. 31

15 февр. 2026 г., 20:42 UTC

Отчет

BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year

15 февр. 2026 г., 20:41 UTC

Отчет

BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year

15 февр. 2026 г., 20:40 UTC

Отчет

BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior

15 февр. 2026 г., 20:40 UTC

Отчет

BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year

15 февр. 2026 г., 20:39 UTC

Отчет

BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited

Сравнение c конкурентами

Изменение цены

Cross Country Healthcare Inc Прогноз

Целевая цена

By TipRanks

22.9% рост

Прогноз на 12 месяцев

Средняя 9.93 USD  22.9%

Максимум 11 USD

Минимум 8.65 USD

Основано на мнении 9 аналитиков Wall Street, спрогнозировавших целевые цены для Cross Country Healthcare Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

9 ratings

1

Покупка

8

Удержание

0

Продажа

Техническая оценка

By Trading Central

13.52 / 13.92Поддержка и Сопротивление

Краткосрочная

Very Strong Bullish Evidence

Среднесрочная

Strong Bearish Evidence

Долгосрочная

Bearish Evidence

Настроения

By Acuity

148 / 406Рейтинг в Промышленность

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Cross Country Healthcare Inc

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services. It also offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, VMS, in- home care, education healthcare, RPO, project management, and other outsourcing and consultative services. This segment provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. It serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. Its Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand on temporary assignments. It serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
help-icon Live chat